SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-070121
Filing Date
2023-03-14
Accepted
2023-03-14 16:02:33
Documents
5
Effectiveness Date
2023-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d439503ds8.htm S-8 32929
2 EX-5.1 d439503dex51.htm EX-5.1 5867
3 EX-23.1 d439503dex231.htm EX-23.1 1415
4 EX-FILING FEES d439503dexfilingfees.htm EX-FILING FEES 19347
5 GRAPHIC g439503dsp008.jpg GRAPHIC 16421
  Complete submission text file 0001193125-23-070121.txt   83518
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270522 | Film No.: 23730672
SIC: 2834 Pharmaceutical Preparations